U.S. markets open in 7 hours 13 minutes
  • S&P Futures

    3,603.50
    +27.50 (+0.77%)
     
  • Dow Futures

    29,808.00
    +262.00 (+0.89%)
     
  • Nasdaq Futures

    11,973.00
    +67.75 (+0.57%)
     
  • Russell 2000 Futures

    1,838.90
    +21.80 (+1.20%)
     
  • Crude Oil

    43.68
    +0.62 (+1.44%)
     
  • Gold

    1,826.70
    -11.10 (-0.60%)
     
  • Silver

    23.46
    -0.17 (-0.73%)
     
  • EUR/USD

    1.1855
    +0.0010 (+0.08%)
     
  • 10-Yr Bond

    0.8570
    0.0000 (0.00%)
     
  • Vix

    22.66
    -1.04 (-4.39%)
     
  • GBP/USD

    1.3340
    +0.0018 (+0.14%)
     
  • USD/JPY

    104.4520
    -0.0360 (-0.03%)
     
  • BTC-USD

    18,376.44
    +43.93 (+0.24%)
     
  • CMC Crypto 200

    368.17
    +6.74 (+1.86%)
     
  • FTSE 100

    6,333.84
    -17.61 (-0.28%)
     
  • Nikkei 225

    26,165.59
    +638.22 (+2.50%)
     

DEADLINE ALERT for EXC, TCNNF, WBAI, and PTLA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

BENSALEM, Pa., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

Exelon Corporation (NASDAQ: EXC)
Class Period: February 9, 2019 - November 1, 2019
Lead Plaintiff Deadline: February 14, 2020

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Exelon and/or its employees were engaged in unlawful lobbying activities; (2) that the foregoing increased the risk of a criminal investigation into Exelon; (3) that ComEd's revenues were in part the product of unlawful conduct and thus unsustainable; and (4) that, as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times.

Trulieve Cannabis Corp. (OTC: TCNNF)
Class Period: September 25, 2018 – December 17, 2019
Lead Plaintiff Deadline: February 28, 2020

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Trulieve overstated its mark-up on its biological assets; (2) that Trulieve's reported gross profit was inflated; (3) that Trulieve engaged in an undisclosed related party real estate sale with Defendant Rivers' husband; and (4) that as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

500.com Limited (NYSE: WBAI)
Class Period: April 27, 2018 – December 31, 2019
Lead Plaintiff Deadline: March 16, 2020

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that 500.com executives and consultants engaged in a bribery scheme with Japanese officials in an effort to gain favor in a bid to run an upcoming Japanese casino resort; (2) that consequently, 500.com was in violation of Japanese anti-bribery laws and its Code of Ethics; and (3) that as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Portola Pharmaceuticals, Inc. (NASDAQ: PTLA)
Class Period: May 8, 2019-January 9, 2020
Lead Plaintiff Deadline: March 16, 2020

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Portola’s internal control over financial reporting regarding reserve for product returns was not effective; (2) that Portola was shipping longer-dated product with 36-month shelf life; (3) that Portola had not established adequate reserve for returns of prior shipments of short-dated product; (4) that, as a result, Portola was reasonably likely to need to “catch up” on accounting for return reserves; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com